| Tocilizumab for treatment of mechanically ventilated patients with COVID-19 EC Somers, GA Eschenauer, JP Troost, JL Golob, TN Gandhi, L Wang, ... Clinical Infectious Diseases 73 (2), e445-e454, 2021 | 515 | 2021 |
| Survival benefit-based deceased-donor liver allocation DE Schaubel, MK Guidinger, SW Biggins, JD Kalbfleisch, EA Pomfret, ... American Journal of Transplantation 9 (4), 970-981, 2009 | 341 | 2009 |
| Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome F Wong, SC Pappas, MP Curry, KR Reddy, RA Rubin, MK Porayko, ... New England Journal of Medicine 384 (9), 818-828, 2021 | 312 | 2021 |
| Liver transplantation for hepatocellular carcinoma: the MELD impact P Sharma, V Balan, JL Hernandez, AM Harper, EB Edwards, ... Liver Transplantation 10 (1), 36-41, 2004 | 291 | 2004 |
| Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon α2b and ribavirin: an open-label series1 H Rodriguez-Luna, A Khatib, P Sharma, G De Petris, JW Williams, J Ortiz, ... Transplantation 77 (2), 190-194, 2004 | 207 | 2004 |
| Re-weighting the model for end-stage liver disease score components P Sharma, DE Schaubel, CS Sima, RM Merion, ASF Lok Gastroenterology 135 (5), 1575-1581, 2008 | 183 | 2008 |
| Renal outcomes after liver transplantation in the model for end‐stage liver disease era P Sharma, K Welch, R Eikstadt, JA Marrero, RJ Fontana, AS Lok Liver transplantation 15 (9), 1142-1148, 2009 | 181 | 2009 |
| Blockchain technology for cloud storage: A systematic literature review P Sharma, R Jindal, MD Borah ACM Computing Surveys (CSUR) 53 (4), 1-32, 2020 | 144 | 2020 |
| Impact of MELD‐based allocation on end‐stage renal disease after liver transplantation P Sharma, DE Schaubel, MK Guidinger, NP Goodrich, AO Ojo, RM Merion American Journal of Transplantation 11 (11), 2372-2378, 2011 | 125 | 2011 |
| Protecting the Kidney in Liver Transplant Recipients: Practicee-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice J Levitsky, JG O’Leary, S Asrani, P Sharma, J Fung, A Wiseman, ... American Journal of Transplantation 16 (9), 2532-2544, 2016 | 122 | 2016 |
| Morphine modulates proliferation of kidney fibroblasts PC Singhal, P Sharma, V Sanwal, A Prasad, A Kapasi, R Ranjan, ... Kidney international 53 (2), 350-357, 1998 | 120 | 1998 |
| Liver transplantation for hepatocellular carcinoma: management after the transplant EC Verna, YA Patel, A Aggarwal, AP Desai, C Frenette, AA Pillai, R Salgia, ... American Journal of Transplantation 20 (2), 333-347, 2020 | 115 | 2020 |
| Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains RY Wu, M Pasyk, B Wang, P Forsythe, J Bienenstock, YK Mao, P Sharma, ... Neurogastroenterology & Motility 25 (3), e205-e214, 2013 | 110 | 2013 |
| End‐stage liver disease candidates at the highest model for end‐stage liver disease scores have higher wait‐list mortality than status‐1A candidates P Sharma, DE Schaubel, Q Gong, M Guidinger, RM Merion Hepatology 55 (1), 192-198, 2012 | 109 | 2012 |
| Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence P Sharma, JA Marrero, RJ Fontana, JK Greenson, H Conjeevaram, GL Su, ... Liver Transplantation 13 (8), 1100-1108, 2007 | 109 | 2007 |
| EHDHE: Enhancing security of healthcare documents in IoT-enabled digital healthcare ecosystems using blockchain P Sharma, S Namasudra, RG Crespo, J Parra-Fuente, MC Trivedi Information Sciences 629, 703-718, 2023 | 106 | 2023 |
| Incidence of and risk assessment for adverse cardiovascular outcomes after liver transplantation: a systematic review MA Konerman, D Fritze, RL Weinberg, CJ Sonnenday, P Sharma Transplantation 101 (7), 1645-1657, 2017 | 100 | 2017 |
| Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: systematic review and meta-analysis N Saeed, L Glass, P Sharma, C Shannon, CJ Sonnenday, MA Tincopa Transplantation 103 (11), e345-e354, 2019 | 99 | 2019 |
| Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors? P Sharma, V Balan, J Hernandez, M Rosati, J Williams, ... Digestive diseases and sciences 49, 25-29, 2004 | 97 | 2004 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 87 | 2021 |
